Pure Global

Embody Insertional Achilles Tendinopathy - Trial NCT05998785

Access comprehensive clinical trial information for NCT05998785 through Pure Global AI's free database. This phase not specified trial is sponsored by Zimmer Biomet and is currently Enrolling by invitation. The study focuses on Insertional Achilles Tendinopathy. Target enrollment is 15 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT05998785
Enrolling by invitation
Device Trial
device
Trial Details
ClinicalTrials.gov • NCT05998785
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Embody Insertional Achilles Tendinopathy
A Multi-Center, Prospective Case Series Evaluating Insertional Achilles Tendinopathy Repair Augmented With TAPESTRY® Biointegrative Implant

Study Focus

TAPESTRY Biointegrative Implant

Observational

device

Sponsor & Location

Zimmer Biomet

Libertyville,Tulsa, United States of America

Timeline & Enrollment

N/A

Aug 02, 2022

Dec 01, 2024

15 participants

Primary Outcome

Pain/VAS

Summary

The primary objective of this study is to evaluate the long-term effects on ankle/Achilles
 tendon pain after repair of insertional Achilles tendinopathy (IAT) augmented with TAPESTRY
 Biointegrative Implant.

ICD-10 Classifications

Achilles tendinitis
Injury of Achilles tendon
Short Achilles tendon (acquired)
Spontaneous rupture of unspecified tendon
Injury of unspecified muscle and tendon at ankle and foot level

Data Source

ClinicalTrials.gov

NCT05998785

Device Trial